Extracorporeal Membrane Oxygenation Complication Clinical Trials

21 recruitingLast updated: June 18, 2026

There are 21 actively recruiting extracorporeal membrane oxygenation complication clinical trials across 16 countries. Studies span Not Applicable, Phase 2, Phase 3. Top locations include Sydney, New South Wales, Australia, Camperdown, New South Wales, Australia, Milan, MI, Italy. Updated daily from ClinicalTrials.gov.


Extracorporeal Membrane Oxygenation Complication Trials at a Glance

21 actively recruiting trials for extracorporeal membrane oxygenation complication are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Sydney, Camperdown, and Milan. Lead sponsors running extracorporeal membrane oxygenation complication studies include Xiaotong Hou, Australian and New Zealand Intensive Care Research Centre, and Assistance Publique - Hôpitaux de Paris.

Browse extracorporeal membrane oxygenation complication trials by phase

Treatments under study

About Extracorporeal Membrane Oxygenation Complication Clinical Trials

Looking for clinical trials for Extracorporeal Membrane Oxygenation Complication? There are currently 21 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Extracorporeal Membrane Oxygenation Complication trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Extracorporeal Membrane Oxygenation Complication clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 21 trials

Recruiting
Phase 3

RECOMMEND Platform Trial

Intensive Care MedicineCritical IllnessCardiac Arrest (CA)+2 more
Australian and New Zealand Intensive Care Research Centre600 enrolled3 locationsNCT06526533
Recruiting
Phase 2

BivaLirudin versUS Heparin in Extracorporeal Membrane Oxygenation

Extracorporeal Membrane Oxygenation Complication
Sydney Local Health District80 enrolled1 locationNCT05959252
Recruiting
Not Applicable

Platform of Randomized Adaptive Clinical Trials in Critical Illness

Respiratory InsufficiencyMechanical Ventilation Pressure HighExtracorporeal Membrane Oxygenation Complication
University Health Network, Toronto6,250 enrolled89 locationsNCT05440851
Recruiting
Phase 3

"Continuous Positive Airway Pressure on Venovenous extracorporeaL Membrane Oxygenation for Acute respIratory Distress syndrOme"

Acute Respiratory Distress SyndromeExtracorporeal Membrane Oxygenation Complication
Assistance Publique - Hôpitaux de Paris280 enrolled11 locationsNCT06814340
Recruiting
Not Applicable

Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation

Extracorporeal Membrane Oxygenation Complication
Xiaotong Hou154 enrolled1 locationNCT06275555
Recruiting

Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock

Septic ShockExtracorporeal Membrane Oxygenation Complication
Children's Hospital of Fudan University60 enrolled1 locationNCT03948048
Recruiting
Phase 2Phase 3

Anticoagulation-free VV ECMO for Acute Respiratory Failure

Extracorporeal Membrane Oxygenation Complication
Damian Ratano40 enrolled1 locationNCT04273607
Recruiting
Not Applicable

Transplantation of Autologously Derived Mitochondria Following Ischemia

Extracorporeal Membrane Oxygenation Complication
Boston Children's Hospital16 enrolled1 locationNCT02851758
Recruiting
Not Applicable

Continuous Compartment Pressure Monitoring for Compartment Syndrome in VA-ECMO Patients

Extracorporeal Membrane Oxygenation ComplicationCompartment Syndrome of LegLimb Ischemia+1 more
Johns Hopkins University6 enrolled1 locationNCT05830721
Recruiting

Evaluating the Safety and Performance of the MiniLung Petite Kit in Neonatal and Pediatric Patients With Acute Respiratory and Cardiac Failure

Acute Lung InjuryAcute Respiratory FailureExtracorporeal Membrane Oxygenation Complication+1 more
Xenios AG20 enrolled2 locationsNCT06750536
Recruiting
Not Applicable

Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO

Extracorporeal Membrane Oxygenation Complication
Xiaotong Hou80 enrolled1 locationNCT06276010
Recruiting
Not Applicable

ECMO ABI Detection With Hyperfine

Acute brain injuryStroke, AcuteExtracorporeal Membrane Oxygenation Complication+1 more
Children's Mercy Hospital Kansas City30 enrolled1 locationNCT06469801
Recruiting

DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study

Extracorporeal Membrane Oxygenation ComplicationExtracorporeal Circulation; Complications
Queen Mary Hospital, Hong Kong50 enrolled1 locationNCT06095518
Recruiting

EUROSETS ECMO Study in Clinical Extracorporeal Life Support Applications

Extracorporeal Membrane Oxygenation Complication
Eurosets S.r.l.30 enrolled1 locationNCT05163925
Recruiting
Not Applicable

Red Blood Cell Transfusion in ECMO - A Feasibility Trial

Disability PhysicalCognitive Ability, GeneralExtracorporeal Membrane Oxygenation Complication+2 more
Australian and New Zealand Intensive Care Research Centre120 enrolled2 locationsNCT05814094
Recruiting
Phase 2

Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO

Cardiogenic ShockExtracorporeal Membrane Oxygenation ComplicationPlatelet Dysfunction
IRCCS San Raffaele50 enrolled1 locationNCT06792643
Recruiting

ECMO LEft Ventricle UNloading Strategy

Cardiac ArrestExtracorporeal Membrane Oxygenation ComplicationShock, Cardiogenic
Maastricht University Medical Center500 enrolled1 locationNCT06766006
Recruiting

Monitoring of Cerebral Blood Flow in Patients on Extracorporeal Membrane Oxygenation

Extracorporeal Membrane Oxygenation ComplicationCerebral Circulatory Failure
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)15 enrolled1 locationNCT05303363
Recruiting

Nosocomial Infections in ECMO Patients

Nosocomial infectionAcute Respiratory Distress SyndromeExtracorporeal Membrane Oxygenation Complication
Policlinico Hospital200 enrolled2 locationsNCT05566665
Recruiting
Not Applicable

Distal Perfusion Timing, Early or Conservative, to Prevent Limb Ischemia During Peripheral VA-ECMO

Extracorporeal Membrane Oxygenation Complication
Min-Seok Kim400 enrolled1 locationNCT05698628